Articles on Stocks
Earnings will flood in from this week on, offering traders and investors an opportunity to evaluate the historic highs and short-term overbought conditions in European and US equities, explains Ian Murphy of MurphyTrading.com.
Ian Murphy
STOCKS
Real estate investment trusts (REITs) recovered from their sharp decline in the early stages of the pandemic recession, observes Bob Carlson, dividend investing expert and editor of Retirement Watch.
Robert Carlson
REITS
AbbVie (ABBV) is the seventh-largest pharmaceutical company on the globe in terms of revenue; the company is also a Dividend Aristocrat, having nearly a half-century of dividend growth to its credit, observes Rida Morwa, income specialist and editor of High Dividend Opportunities.
Rida Morwa
HEALTHCARE
Tickers: ABBV
Space used to be a black hole where investment dollars went to die. Today investors see only opportunity as the economics of the sector reset. This is the best way to gain exposure, suggests Jon Markman, a visionary growth investor and editor of Strategic Advantage.
Jon Markman
TECHNOLOGY
Tickers: ARKX
Protech Home Medical (Vancouver: PTQ) (OTC: PTQQF) provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market, explains Ryan Irvine, contributing editor to Internet Wealth Builder.
Ryan Irvine
HEALTHCARE
Tickers: PTQ:CA
Among the first and hardest hit retailers from last year’s pandemic were personal care stores such as hair and nail salons, and Sally Beauty (SBH) suffered due to that trend, notes growth stock expert Mike Cintolo, editor of Cabot Top Ten Trader.
Michael Cintolo
CONSUMER
Tickers: SBH
Sponsored Content - Do you need to do some spring cleaning in your investment portfolio or have existing real estate securities that are not performing the way you want, asks Chris Loeffler, CEO and co-founder, Caliber.
Chris Loeffler
REITS
While we saw a lot of mass vaccination sites pop up in 2021 as vaccines saw their initial rollout, this won’t continue to be the case. Instead, like you do for the flu shot, you’ll go to your doctor’s office, pharmacy, or drugstore for a yearly COVID booster, suggests Genia Turanova, editor of Unlimited Income.
Genia Turanova
HEALTHCARE
Tickers: CVS
The airline business has shifted towards the leisure traveler. "Are Americans ready to travel once again?," asks Boris Schlossberg of BK Asset Management.
Boris Schlossberg
TRANSPORTATION
Tickers: LUV
Our stocks are acting well from a chartist’s perspective; many of them are also likely to benefit from various spending initiatives that are coming out of Washington these days, suggests Nate Pile, editor of Little River Investment Guide.
Experts on Stocks
$139.00
1:57:53
Virtual Expos
Virtual Learning
The strong dollar and competition from bitcoin has caused a unique opportunity to buy the fastest growth gold miner in the world. It has 39% profit margin, doubled its dividend, and produced over one million ounces of gold last year.
Mark Skousen
STOCKS
33:39
ShiftPixy is a disruptive human capital services enterprise, revolutionizing employment in the gig economy by delivering a next-gen platform for workforce management that helps businesses with shift-based employees navigate regulatory mandates, minimize administrative burdens, and better connect with a ready-for-hire workforce. With expertise rooted in management's nearly 25 years of workers' compensation and compliance programs experience, ShiftPixy adds a needed layer for addressing compliance and continued demands for equitable employment practices in the growing gig economy. ShiftPixy's complete human capital management ecosystem is designed to manage regulatory requirements and compliance in such required areas as paid time off (PTO) laws, insurance and workers' compensation, minimum wage increases, and Affordable Care Act (ACA) compliance.
Scott Absher
TECHNOLOGY
20:52
Right now there is an enormous opportunity within the small cap sector to find high growth disruptive companies trading at significant discounts to their future earnings potential. When you consider the large number of innovative companies coming public via SPAC, it's turning into an incredible time to be a small cap growth investor. In Jonah Lupton's presentation, he will share how he finds these companies, his due diligence process, why he believes small cap growth is an exciting place to invest in, and what kinds of returns he is expecting from his top picks.
Jonah Lupton
STOCKS
30:39
Peter Holst, CEO of Oblong, will provide an overview of Oblong's flagship MezzanineTM remote meeting technology platform, which offers simultaneous content sharing to enhance productivity through higher levels of engagement for hybrid workforces, both in-person and remote. Mr. Holst will also discuss how its solutions create optimal user experiences for its Fortune 500 customer base, its global distribution agreement with Cisco Webex, its large and growing market, its strong intellectual property portfolio, and its strategy to expand to a hybrid cloud delivery with a Mezzanine SaaS offering.
Peter Holst
TECHNOLOGY
32:11
What has worked in the past likely won't provide the same outperformance in the future. The next FAANG outlines areas of tech leadership for the next decade.
Gene Munster
TECHNOLOGY
30:45
The stock market is benefitting from very easy year over year sales & earnings comparisons due to the pandemic a year ago. These easy year over year comparisons will persist throughout 2021, but the first quarter will be the peak for sales and earnings momentum. After the positive first quarter announcement season winds down in May, Louis Navellier expects that the overall stock market will become increasingly narrow and fundamentally focused. He will explain how he utilizes his Dividend Grader and Stock Grader databases to find the creme a la creme. Naturally, Mr. Navellier will also reveal his best A-rated stock picks as well as the few select "AA stocks" that get a A-rating in both his Dividend Grader and Stock Grader databases!
Louis Navellier
STOCKS
30:24
The multi-trillion-dollar travel industry is about to undergo a major disruption as we recover from Covid-19 and as the millennial generation now becomes the major customer set. We all travel, so these upcoming changes will affect everyone. More importantly, knowing about these coming changes before they happen can help you invest ahead of the curve and reap maximum profit. Learn about the technology the industry will need to recover from Covid-19 and to serve the millennial generation. More importantly, learn about the company that has pioneered the technology that solves these problems and installed it in some of the largest Hilton and Marriott hotels in the country. Kevin Bidner, a CEO with a $500M exit in his history, who heads up The Hotel Communication Network, gives an enlightening talk about how you can get ahead of the curve and benefit from the changes to come.
Kevin Bidner
TECHNOLOGY
31:13
How we move is changing fast and it's not about building a faster Tesla. 30-ft drones transport US Air Force personnel across sprawling bases. Fuel cells power construction equipment, lifting thousands of pounds. Electric delivery vans make UPS greener and our air cleaner. Several pioneering companies are propelling the world forward at record speed. The question is which ones to buy today? Join Adam Johnson to discover how the future of mobility is now.
Adam Johnson
TECHNOLOGY
33:37
Zhittya Genesis Medicine, Inc., is developing novel pharmaceuticals that have the potential to treat and reverse diseases that account for more than 50% of all adult deaths, worldwide. In FDA-authorized clinical trials these drugs have shown remarkable success in reversing severe coronary artery disease and healing chronic diabetic foot ulcers. New clinical trials are planned in the coming year to treat patients with Parkinson's disease, ALS (Lou Gehrig's disease), multiple sclerosis, chronic stroke, and Alzheimer's disease. A very attractive Pre-IPO investment is now being offered to suitable investors to help fund the upcoming IPO, which has a firm commitment from a highly regarded securities firm and will take place in 5-6 months.
Daniel Montano
BIOTECH
30:04
Many experts say we're in the golden age of biotechnology, with this sector presenting tremendous opportunities for investors. While Pre-IPO opportunities are traditionally reserved for institutional funds, now you can get in on the ground-floor of this biotech company working to halt and perhaps even reverse disease progression in people living with debilitating diseases with no cures, such as multiple sclerosis and Parkinson's disease, and rare diseases including systemic sclerosis and Huntington's disease—for which it has Orphan Designation—through the convergence of biology, science, and cannabinoids. Join Dr. Jim DeMesa as he provides further insight into this unique investment opportunity.
Jim DeMesa
BIOTECH
31:21
Face-to-Face Conferences
Conferences
Cruises
Sponsored Content
While the mechanisms and machinations of the markets have changed a lot since Benjamin Graham first devised a practical method for analyzing stocks, or even since Peter Lynch racked up big wins picking equities for Fidelity's Magellan Fund, one thing remains true: companies that deliver constant profits for shareholders will see their share prices increase.
Lofty current valuations show that the easy money has already been made, and those looking to profit should be more selective going forward. So which sectors will lead the market over the months ahead? What’s the best way to limit risk in the current environment? You will find the answers to these questions and more from the top industry professionals on these pages, unlike watching the stock market news on TV. Going beyond the stock market news today, many investors are searching for investments that they can depend on. Of course, there's no such thing as a sure bet, but the top experts featured here will share the picks they think are the next best things and the sectors that are bound to thrive in the days and months ahead.
The current market environment is particularly well-suited for stock pickers and stock-trading experts—especially the experts featured here whose careers are devoted to uncovering the best opportunities available in even the most rapidly changing environment. Get easy access to the nation’s leading stock experts who regularly share their takes on where market trends are headed, where to find bargains, and how to stay ahead of the curve.
Watch videos and read articles by these experts and discover their outlooks on what’s ahead for stocks, but more importantly, identify the most compelling sectors and industry groups, as well as the specific buying opportunities for optimal growth or income. These pages are chock-full of valuable insights from our experts' varying perspectives and expertise.